-
Purpose(Empty Backbone) Doxycycline inducible dCas9-KRAB targeting construct for AAVS1 locus
-
Depositing Lab
-
Sequence Information
Ordering
This material is available to academics and nonprofits only.
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 115545 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 | |
Backbone
-
Vector backbonepAAVS1-TetOn-dCas9-KRAB
- Backbone size (bp) 13225
-
Vector typeMammalian Expression, Bacterial Expression
- Promoter CAG
-
Selectable markersNeomycin (select with G418)
-
Tag
/ Fusion Protein
- HA (C terminal on insert)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberUnknown
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
How to cite this plasmid
( Back to top)
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pAAVS1-TetOn-dCas9-KRAB was a gift from Rene Maehr (Addgene plasmid # 115545 ; http://n2t.net/addgene:115545 ; RRID:Addgene_115545) -
For your References section:
Single-Cell RNA-Sequencing-Based CRISPRi Screening Resolves Molecular Drivers of Early Human Endoderm Development. Genga RMJ, Kernfeld EM, Parsi KM, Parsons TJ, Ziller MJ, Maehr R. Cell Rep. 2019 Apr 16;27(3):708-718.e10. doi: 10.1016/j.celrep.2019.03.076. 10.1016/j.celrep.2019.03.076 PubMed 30995470
Map uploaded by the depositor.
